Search Clinical Trials
Home > Clinical Trials & Research > Search Clinical Trials

Clinical Trials & Research

Search Clinical Trials

Clinical Trials

New Search
Title   EPOCH Chemotherapy and Bortezomib for Associated T-Cell Leukemia Lymphoma (ATLL)
Description   The purpose of the study is to explore the use of combination chemotherapy together with antiretroviral agents in order to determine the efficacy and toxicity of this approach, while also examining markers of virus replication and expression, and tumor cell proliferation to gain understanding of the biological basis of this malignancy and to identify predictors of response.

Eligibility Criteria   To be eligible for this study, patients must meet several criteria, including but not limited to the following:

* Patient must be 18 Years and older

* Patient must have histologically or cytologically documented ATLL. Patients with previously untreated or treated ATLL are eligible.

* Measurable disease must be present.
Principal Investigator   Sanjay. Parekh, MD
Contact Name   Dale Wyville, PA
Phone   (718) 405-8547
Contact Email
Post Date   10/19/2009
Protocol Number   2010-567/East
Status   Recruiting
Current Trial Type   Interventional
Adult Clinical Trial   No
Pediatric Clinical Trial   No